Depression and thyroid axis function in coronary artery disease: Impact of cardiac impairment and gender

Clinical Cardiology

Volumn 29, Issue 4, 2006, Pages 170-174

  Bunevicius, Robertas ^a,b   Varoneckas, Giedrius ^a   Prange Jr , Arthur J ^b   Hinderliter, Alan L ^b   Gintauskiene, Vilte ^a   Girdler, Susan S ^b  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac impairment; Coronary artery disease; Depression; Gender; Low T3 syndrome; N amino terminal fragment of the pro B type natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; LIOTHYRONINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DEPRESSION; DISABILITY; FEMALE; FREE LIOTHYRONINE INDEX; GENDER; HEART DISEASE; HEART FAILURE; HEART REHABILITATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; QUALITY OF LIFE; THYROID FUNCTION;

CORONARY ARTERIOSCLEROSIS; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYPOTHYROIDISM; INCIDENCE; LITHUANIA; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEX FACTORS; THYROID FUNCTION TESTS; TRIIODOTHYRONINE;

EID: 33645822124     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960290409     Document Type: Article

References (28)

1. Rudisch B, Nemeroff CB: Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003;54:227-240
2. Ades PA, Savage PD, Tischler MD, Poehlman ET, Dee J, Niggel J: Determinants of disability in older coronary patients. Am Heart J 2002;143:151-156
3. Beck CA, Joseph L, Belisle P, Pilote L, and the QOLAMI Investigators (Quality Of Life in Acute Myocardial Infarction): Predictors of quality of life 6 months and 1 year after acute myocardial infarction. Am Heart J 2001;142:271-279
4. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med 2004;66:802-813
5. Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509
6. Prange AJ Jr: Psychoendocrinology. A commentary. Psychiat Clin North Am 1998;21:491-505
7. Wartofsky L, Burman KD: Alterations in thyroid function in patients with systemic illness: The "euthyroid sick syndrome." Endocr Rev 1982;3:164-217
8. Friberg L, Drvota V, Bjelak AH, Eggertsen G, Ahnve S: Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med 2001;111:699-703
9. Klemperer JD: Thyroid hormone and cardiac surgery. Thyroid 2002;12:517-521
10. Hamilton MA, Stevenson LW, Luu M, Walden JA: Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990;16:91-95
11. 3 syndrome: A strong prognostic predictor of death in patients with heart disease. Circulation 2003;107:708-713
12. Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A, Iervasi G: Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 2005;118:132-136
13. Ascheim DD, Hryniewicz K: Thyroid hormone metabolism in patients with congestive heart failure: The low triiodothyronine state. Thyroid 2002;12:511-551
14. Emdin M, Passino C, Prontera C, Iervasi A, Ripoli A, Masini S, Zucchelli GC, Clerico A: Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. Clin Chem Lab Med 2004;42:627-636
15. Baughman K: B-type natriuretic peptide - a window to the heart. N Engl J Med 2002;347:158-159
16. Haggerty JJ Jr, Stern RA, Mason GA, Beckwith J, Morey CE, Prange AJ Jr: Subclinical hypothyroidism: A modifiable risk factor for depression? Am J Psychiat 1993;150:508-510
17. Fava M, L'Abbate LA, Abraham ME, Rosenbaum JF: Hypothyroidism and hyperthyroidism in major depression revisited. J Clin Psychiat 1995;56:186-192
18. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiat Scand 1983;67:361-370
19. Bjerkeset O, Nordahl HM, Myklerun A, Holmen J, Dahl AA: Anxiety and depression following myocardial infarction: Gender differences in a 5-year prospective study. J Psychosom Res 2005;58:153-161
20. Jenkinson C, Layte R, Wright L, Coulter A: the U.K. SF-36: An Analysis and Interpretation Manual: A Guide to Health Status Measurement with Particular Reference to the Short Form 36 Health Survey. Oxford, England: Health Services Research Unit, 1996
21. Parissis JT, Adamopoulos S, Rigas A, Kostakis G, Karatzas D, Venetsanou K, Kremastinos DT: Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 2004;94:1326-1328
22. Shanoudy H, Soliman A, Moe S, Hadian D, Veldhuis JD, Iranmanesh A, Russell DC: Early manifestations of "sick euthyroid" syndrome in patients with compensated chronic heart failure. J Card Fail 2001;7:146-152
23. Seminara SB, Daniels GH: Amiodarone and the thyroid. Endocr Pract 1998;4:48-57
24. Wiersinga WM: Propranolol and thyroid hormone metabolism. Thyroid 1991;1:273-277
25. Abbey SE, Stewart DE: Gender and psychosomatic aspects of ischemic heart disease. J Psychosom Res 2000;48:417-423
26. Stem MJ, Pascale L, Ackerman A: Life adjustment postmyocardial infarction: Determining predictive variables. Arch Intern Med 1977;137:1680-1685
27. Vanderpump MPJ: The epidemiology of thyroid disease. In Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, ninth edition (Eds. Braverman LE, Utiger RD), pp 398-406. Philadelphia: Lippincott Williams and Wilkins, 2005
28. Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction. Impact on 6-month survival. J Am Med Assoc 1993;270:1819-1825.